22 May 2013
Keywords: sandimmun, set, decline, says, analyst, sales, swiss
Article | 27 June 1994
Sales of Swiss pharmaceutical major Sandoz' immunosuppressant drug
Sandimmun (ciclosporin) are likely to decline dramatically from their
current level of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 June 1994
© 2013 thepharmaletter.com